FRIDAY, Feb. 14, 2025 -- Attention-deficit/hyperactivity disorder (ADHD) symptoms are associated with onset of nicotine and tobacco use in U.S....

Semaglutide, used for diabetes and obesity, may reduce alcohol cravings in adults with alcohol use disorder, offering a potential solution to a...

WEDNESDAY, Feb. 19, 2025 -- Traumatic experiences are independently associated with endometriosis, according to a study published online Feb. 5 in...

FRIDAY, Feb. 14, 2025 -- A small number of individuals with mental and substance use disorders receive guideline-consistent treatment worldwide,...

FRIDAY, Feb. 28, 2025 -- Many patients with advanced cancer receive potentially aggressive care in the last month of life at the expense of supportive...

THURSDAY, Feb. 20, 2025 -- Both perceived and actual overweight status may be associated with suicidal ideation among adolescents, according to a...

THURSDAY, Feb. 20, 2025 -- Physical activity and screen time in childhood impact perceived stress and depressive symptoms in adolescence, according...

FRIDAY, Feb. 21, 2025 -- Higher calcium intake is associated with reduced colorectal cancer (CRC) risk across tumor sites and calcium sources,...

WEDNESDAY, Feb. 26, 2025 -- For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic...

The hormone glucagon-like peptide 1 (GLP-1) is effective in controlling insulin release and reducing appetite. It is marketed as Semaglutide, Ozempic...